NEOGENTC Trademark

Trademark Overview

On Wednesday, May 26, 2021, a trademark application was filed for NEOGENTC with the United States Patent and Trademark Office. The USPTO has given the NEOGENTC trademark a serial number of 79314590. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, October 4, 2022. This trademark is owned by NeogenTC Corp.. The NEOGENTC trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; biotechnological research; biological research; research of crude medicines; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical research; clinical studies of medicines; medical research
neogentc

General Information

Serial Number79314590
Word MarkNEOGENTC
Filing DateWednesday, May 26, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, October 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkNEOGEN TC
Goods and ServicesResearch and development of vaccines and medicines; biotechnological research; biological research; research of crude medicines; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical research; clinical studies of medicines; medical research

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeogenTC Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, October 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 4, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 27, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, December 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 7, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, October 4, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, October 4, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, October 4, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, April 11, 2022REFUSAL PROCESSED BY IB
Friday, March 18, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 18, 2022REFUSAL PROCESSED BY MPU
Saturday, February 19, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 18, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 17, 2022NON-FINAL ACTION WRITTEN
Wednesday, February 9, 2022ASSIGNED TO EXAMINER
Friday, January 28, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 3, 2021LETTER OF PROTEST EVIDENCE FORWARDED
Saturday, July 10, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, July 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 1, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

neogentc research medicines medical cancerous diseases pharmaceutical studies clinical field scientific